Defense drone manufacturer ramping a $150-180M annual revenue target from a Q1 base of $15.5M (+849% YoY). Real contracts (US Army SRR, Japan MoD 173-system Black Widow, Ukraine USV partnership) and strong macro tailwind (NATO drone procurement) underwrite the thesis, but the equity is already pricing the optimistic execution path: EV/forward-revenue ~10-12× sits above peer median. Class action overhang on production-capacity and SRR-contract-value misstatements (class period Mar 2022 – Jan 2025) plus $16M of insider sales pre-Kerrisdale report are material governance flags. Strong cash post-May 2026 $225M raise removes capital risk; execution and litigation risk dominate.
Methodology: Primary metric EV/forward revenue (no profitability path yet); revenue base $165M (FY26 guidance mid). Multiple 7× sits between blue-chip defense (AVAV 6-8×) and early drone names (ONDS/UMAC 7-15×). Class action settlement modeled at $25-50M midpoint (typical securities fraud with material misstatement allegation, no SEC enforcement disclosed). Sensitivity: ±1× multiple = ±$1.10/sh; ±$20M settlement = ±$0.13/sh. The fair-value gap between base ($12.50) and current ($14.74) reflects the market pricing the upper end of execution success vs the rNPV-style probability-weighted expectation. ⚠️ Not investment advice.
| Component | Assumption | USD/share |
|---|---|---|
| Core EV (revenue × multiple) | FY26E revenue mid $165M × 7× EV/Rev fw (peer median ~7×, AVAV 8× vs KTOS 5×) = $1,155M EV / 152M shares | +7.60 |
| Cash post May 2026 raise | $131.9M (Mar 31) + $225M gross raise − ~$10M issuance costs − ~$30M Q2 burn = ~$315M net cash / 152M | +2.07 |
| FY27 ramp option value | Probability-weighted $250M FY27E revenue × 5× EV/Rev × 60% PoS hitting target = $750M risk-adj EV / 165M FD shares = $4.55 ÷ 1.5 discount factor | +3.03 |
| Class action settlement reserve | Estimated $25-50M settlement (typical securities fraud with material misstatement allegation), midpoint $37M / 152M shares | −0.24 |
| Future dilution drag | Modeled +5% share count over 12-18mo from stock-based comp + warrant exercise = ~8M shares × $12 base FV = $96M dilution / 152M | −0.63 |
| Governance discount | −10% multiple haircut for class action + insider selling Nov 2024 ($16M pre-disclosure) reduces base FV by ~$1.30/sh — only partly already in multiple | −1.33 |
| FV base case | Sum of rows above | ≈ $12.50 |
Insider transactions in 12 months: CEO Jeffrey Thompson + CFO Leah Lunger sold 1.9M shares for $16M+ in Nov 2024 immediately after SRR contract announcement and before Kerrisdale short report. This is the central piece of evidence in the active class action and derivative suits. No additional material open-market sales in 2025-2026; activity reduced to routine RSU tax-withholding. Insider holdings remain meaningful but the Nov 2024 sales weigh heavily on management trust assessment.
| Item | FY 2023 | FY 2024 | FY 2025 | Q1 FY26 | FY26E target |
|---|---|---|---|---|---|
| Revenue ($M) | 13.0 | 17.5 | 40.0 | 15.5 | 150-180 |
| Gross margin % | −15% | −25% | 5% | 12.7% | ~30% target |
| Operating loss ($M) | −25 | −30 | −45 | −15 | Loss expected through FY26 |
| Cash ($M, end of period) | 5.5 | 15.0 | 167.9 | 131.9 | ~350 post May raise |
| Inventory + prepaid ($M) | 3.5 | 8.0 | 30.4 | 62.7 | scaling for backlog |
| Shares outstanding (M) | 55 | 75 | 120 | 128 | 152 post raise |
| Metric | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|---|---|
| Revenue ($M) | 1.6 | 2.8 | 9.7 | 18.5 | 15.5 |
| Gross margin % | −52% | −10% | 2% | 8% | 12.7% |
| Operating loss ($M) | −9.0 | −10.5 | −12.0 | −13.5 | −15.0 |
| End-of-period cash ($M) | 17.0 | 14.5 | 206.4 | 167.9 | 131.9 |
Business model — Defense unmanned aerial & maritime systems
US Army SRR (Black Widow) ~$80-100M FY26E (~55% rev) 🟢 ramping Multi-year IDIQ from Nov 2024 award. Class action centers on whether actual contract scope/value matches public statements. Production ramp is the key execution variable. International defense (Japan, NATO) ~$40-60M FY26E (~30% rev) 🟢 ramping Japan MoD 173-system Black Widow win + undisclosed NATO ally orders. Faster sales cycle, higher margin potential. Most credible non-US growth lever. Ukraine USV partnership (STE) ~$5-10M FY26E (~3-5% rev) 🟡 to prove Strategic partnership with Ukraine MoD enterprise STE on next-gen uncrewed surface vessels. Long-cycle; early-stage revenue. Reputational + IP optionality.
Strategic optionality: USV maritime expansion is the highest-multiple optionality (USVs are a structurally underserved segment with NATO + Pacific Command demand). Black Widow follow-on procurement from non-US customers post-Japan win can replicate AeroVironment's Switchblade international template. Class action settlement is the asymmetric overhang: any number above $50M materially impairs near-term shareholder returns.
Legal, regulatory and risk analysis
SWOT analysis
- +US Army SRR program-of-record (multi-year IDIQ).
- +~$350M cash post-raise — 24+ months runway.
- +Q1 FY26 revenue +849% YoY, gross margin turned positive.
- +Japan MoD 173-unit Black Widow win — international validation.
- +Production capacity reportedly expanded 520% YoY (FY25).
- −Active class action with material settlement risk.
- −CEO/CFO insider sales in Nov 2024 ($16M+) pre-bad-news.
- −Gross margin 12.7% vs 30% target — large gap.
- −~80% US DoD customer concentration.
- −EV/forward-revenue ~11.7× already prices the upper end.
- →USV maritime expansion via Ukraine STE partnership.
- →Black Widow follow-on procurement from Japan + new NATO members.
- →Pacific Command sUAS demand (Taiwan, Australia, Philippines).
- →Strategic acquirer interest at execution proof point.
- !Class action settlement $50M+ → equity value impairment.
- !SRR contract scope reduction or delivery slip.
- !Competitive entry from AVAV, Anduril, Skydio in same niches.
- !DoD budget continuing resolution / appropriations risk.
Summary by assessment area
- ~$350M cash post-raise removes capital risk.
- No debt; capital structure clean.
- Burn $15M/qtr sustainable for ~24+ months.
- Q1 FY26 only 9% of FY guidance midpoint — back-loaded.
- Gross margin must scale from 12.7% → 30% by FY27.
- SRR program execution under litigation scrutiny.
- Active class action with material settlement risk.
- Insider Nov 2024 sales remain governance overhang.
- Two derivative actions add fiduciary risk layer.
Sources: Red Cat Holdings SEC filings (10-Q Q1 FY26, 8-K Q1 FY26 results, 8-K $225M equity raise May 2026, 8-K Q3 FY25 cash position, DEF 14A proxy), StockTitan, Simply Wall St, Yahoo Finance, Benzinga analyst ratings, Levi & Korsinsky and Rosen Law Firm class action notices, Kerrisdale Capital short report (Jan 2025), Roth Capital / HC Wainwright / Needham research notes. Market data — last verified close 2026-06-05 (T-1 trading day from report date): RCAT $14.74, market cap ~$2.24B, 152.19M shares outstanding (post May 2026 raise of 23.94M shares at $9.40), 52W range approximately $4-$15. Short interest ~22% (elevated; Kerrisdale legacy). Q1 FY26 revenue $15.5M (+849% YoY), gross margin 12.7%, operating loss ~$15M, cash $131.9M + $225M raise = ~$350M est. FY26 revenue target $150-180M, GM target 30%. Active class action: Olsen v. Red Cat Holdings, D.N.J. 25-cv-05427 (class period Mar 18, 2022 – Jan 15, 2025). ⚠️ This document is for informational purposes only and does not constitute financial or investment advice.